XML 61 R33.htm IDEA: XBRL DOCUMENT v3.23.1
STOCK OPTIONS (Tables)
12 Months Ended
Dec. 31, 2022
Share-Based Payment Arrangement [Abstract]  
SCHEDULE OF STOCK BASED COMPENSATION EXPENSES

Total stock-based compensation expense recognized for both employees and non-employees was as follows:

   2022   2021   2020 
   Years Ended December 31, 
   2022   2021   2020 
     
General and administrative  $11,183   $7,462   $7,611 
Research and development   7,845    4,377    5,612 
Total stock-based compensation expense  $19,028   $11,839   $13,223 
SUMMARY OF STOCK OPTION ACTIVITY

A summary of option activity for the years ended December 31, 2022 and 2021 are presented below:

           Weighted-     
       Weighted-   Average     
       Average   Remaining     
   Underlying   Exercise   Contractual   Intrinsic 
Stock Option Awards  Shares   Price   Term   Value 
                 
Outstanding at December 31, 2020   9,503   $9.10    8.3 years      
Granted   4,104   $7.37           
Exercised   (19)  $2.50           
Forfeited or expired   (1,115)  $9.76           
Outstanding at December 31, 2021   12,473   $8.48    8.0 years      
Granted   3,706   $4.83           
Exercised   (566)  $2.75           
Forfeited or expired   (775)  $8.83           
Outstanding at December 31, 2022   14,838   $7.77    7.3 years   $53,687 
Exercisable at December 31, 2022   7,617   $8.39    6.2 years   $24,804 
SCHEDULE OF AGGREGATED INTRINSIC VALUE OF STOCK OPTION EXERCISED

Cash proceeds from, and the aggregate intrinsic value of, stock options exercised during the periods presented below were as follows:

 

   2022   2021   2020 
   Years Ended December 31, 
   2022   2021   2020 
     
Cash proceeds from options exercised  $1,036   $48   $1,152 
Aggregate intrinsic value of options exercised  $3,420   $239   $1,615 
SCHEDULE OF SHARE-BASED COMPENSATION VALUATION OF ASSUMPTIONS

The Company uses the Black-Scholes option-pricing model to estimate the fair value of option awards with the following weighted-average assumptions for the period indicated:

 

   Years Ended December 31, 
   2022   2021   2020 
             
Exercise price  $4.83   $7.37   $12.87 
Expected volatility   80%   81%   74%
Expected dividends            
Expected term (in years)   6.1    6.1    6.2 
Risk-free interest rate   2.16%   1.13%   0.59%